Company Profile For Alcon Inc

Alcon, Inc. (Alcon) is a research and development driven, global medical specialty company focused on eye care. The Company develops, manufactures and markets pharmaceuticals, surgical equipment and devices and consumer eye care products to treat diseases and disorders of the eye. Alcon manages its business through two segments: Alcon United States and Alcon International. Its portfolio spans three key ophthalmic categories: pharmaceutical, surgical and consumer eye care products. In its pharmaceutical category Alcon develops, manufactures and markets a range of prescription ophthalmic pharmaceutical products. Alcon offers a range of surgical equipment, single-use and disposable products. The Company markets contact lens care products, artificial tears and ocular vitamins, in its consumer eye care products category. In July 2008, Novartis AG acquired a 25% stake in Alcon from Nestle SA.

BRIEF: For the nine months ended 30 September 2009, Alcon, Inc.'s revenues decreased less then 1% to $4.78B. Net income decreased 5% to $1.55M. Revenues reflect a decrease in income from Pharmaceutical, lower revenue from Surgical and decreased revenue from Consumer Eye Care segment. Net income was offset by a decrease in gross profit and lower interest income. The Company is engaged in develops, manufacturing and marketing of pharmaceuticals devices.

Alcon Inc
Boesch 69
Huenenberg     6331
P: +4141.7858888

15400